Search

Tate & Lyle PLC

Fechado

SetorConsumo Básico

379 0.11

Visão Geral

Variação de preço das ações

24h

Atual

Mín

379

Máximo

381

Indicadores-chave

By Trading Economics

Rendimento

-22M

Vendas

961M

P/E

Médio do Setor

31.717

29.307

EPS

0.2

Rendimento de Dividendos

5.13

Margem de lucro

-2.289

Funcionários

4,971

EBITDA

93M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+26.62% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.13%

3.55%

Próxima data de dividendos

5 de jan. de 2026

Próxima data de ex-dividendo

20 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.7B

Abertura anterior

378.89

Fecho anterior

379

Sentimento de Notícias

By Acuity

76%

24%

135 / 148 Ranking em Consumer defensive

Tate & Lyle PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de nov. de 2025, 21:06 UTC

Grandes Movimentos do Mercado

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8 de nov. de 2025, 18:10 UTC

Ganhos

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8 de nov. de 2025, 13:10 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 de nov. de 2025, 12:00 UTC

Ganhos

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8 de nov. de 2025, 10:30 UTC

Ganhos

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8 de nov. de 2025, 03:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 de nov. de 2025, 03:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 de nov. de 2025, 03:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 de nov. de 2025, 22:36 UTC

Ganhos

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 de nov. de 2025, 22:22 UTC

Ganhos

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 de nov. de 2025, 22:03 UTC

Ganhos

Constellation Software 3Q Rev $2.95B >CSU.T

7 de nov. de 2025, 22:03 UTC

Ganhos

Constellation Software 3Q Net $210M >CSU.T

7 de nov. de 2025, 22:03 UTC

Ganhos

Constellation Software 3Q EPS $9.89 >CSU.T

7 de nov. de 2025, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

7 de nov. de 2025, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

7 de nov. de 2025, 20:59 UTC

Ganhos

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 de nov. de 2025, 20:26 UTC

Conversa de Mercado

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 de nov. de 2025, 20:22 UTC

Ganhos

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 de nov. de 2025, 20:04 UTC

Conversa de Mercado

Oil Futures Close Choppy Week With Losses -- Market Talk

7 de nov. de 2025, 19:34 UTC

Conversa de Mercado

Gold Posts Small Gain for Week -- Market Talk

7 de nov. de 2025, 19:31 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 de nov. de 2025, 19:17 UTC

Ganhos

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 de nov. de 2025, 19:09 UTC

Ganhos

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 de nov. de 2025, 19:08 UTC

Ganhos

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 de nov. de 2025, 18:31 UTC

Conversa de Mercado

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 de nov. de 2025, 17:27 UTC

Conversa de Mercado

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 de nov. de 2025, 17:20 UTC

Conversa de Mercado

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 de nov. de 2025, 17:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

7 de nov. de 2025, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

7 de nov. de 2025, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

Tate & Lyle PLC Previsão

Preço-alvo

By TipRanks

26.62% parte superior

Previsão para 12 meses

Média 487.5 GBX  26.62%

Máximo 630 GBX

Mínimo 390 GBX

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Tate & Lyle PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

8 ratings

4

Comprar

3

Manter

1

Vender

Sentimento

By Acuity

135 / 148 Ranking em Consumo Básico

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Tate & Lyle PLC

Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverage, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. The company operates through three segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and Primient. It offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; sweeteners, such as high fructose corn syrup and dextrose; industrial starches; acidulants; and corn gluten feed and meal and corn oil. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
help-icon Live chat